Karin Leander
-
- Atrial Fibrillation Management and Outcomes 7
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
-
- Atherosclerosis and Cardiovascular Diseases 8
-
- Adipokines, Inflammation, and Metabolic Diseases 13
-
- Obesity, Physical Activity, Diet 8
- Nutritional Studies and Diet 8
-
- Lipoproteins and Cardiovascular Health 7
-
- Fatty Acid Research and Health 6
- Co-authors
- Ulf dé FairéBruna GiganteMai-Lis HelléniusJohan HallqvistAxel C. CarlssonRebecka HultgrenMax VikströmJohnny Steuer
- Cited by
- Cardiology and Cardiovascular MedicineHealth, Toxicology and MutagenesisEndocrinology, Diabetes and Metabolism
- Partner nations
- SwedenUnited StatesItaly
In The Last Decade
Karin Leander
88 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Cardiology and Cardiovascular Medicine 577
- Health, Toxicology and Mutagenesis 291
- Endocrinology, Diabetes and Metabolism 326
- Pulmonary and Respiratory Medicine 337
- Immunology 210
Countries citing papers authored by Karin Leander
This map shows the geographic impact of Karin Leander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Leander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Leander more than expected).
Fields of papers citing papers by Karin Leander
This network shows the impact of papers produced by Karin Leander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Leander. The network helps show where Karin Leander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karin Leander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 13 | |
| 8 | 2019 | 14 | |
| 9 | 2017 | 38 | |
| 10 | 2015 | 53 | |
| 11 | 2014 | 24 | |
| 12 | 2013 | 30 | |
| 13 | 2013 | 60 | |
| 14 | 2012 | 14 | |
| 15 | 2012 | 17 | |
| 16 | 2011 | 14 | |
| 17 | The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project : Thrombosis Research | 2005 | 2 |
| 18 | The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women : Journal of Internal Medicine | 2002 | 5 |
| 19 | 2002 | 25 | |
| 20 | 2001 | 112 |
About Karin Leander
Karin Leander is a scholar working on Chemical Health and Safety, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 92 papers that have together received 2.3k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Obesity, Physical Activity, Diet (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Nutritional Studies and Diet (8 papers), Lipoproteins and Cardiovascular Health (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Fatty Acid Research and Health (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (577 citations), Health, Toxicology and Mutagenesis (291 citations) and Endocrinology, Diabetes and Metabolism (326 citations). Karin Leander has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Ulf dé Fairé, Bruna Gigante, Mai-Lis Hellénius, Johan Hallqvist, Axel C. Carlsson, Rebecka Hultgren, Max Vikström, Johnny Steuer, Fredrik Nyberg and Anders Hamsten. Their work appears in journals such as PLoS ONE, Journal of Internal Medicine, Circulation, PLoS Medicine and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.